Differential attenuation of some effects of haloperidol in rats given scopolamine

European Journal of Pharmacology
P E SetlerG M McKenzie


In a series of pharmacological tests the ability of 0.6 mg/kg of the anticholinergic scopolamine to decrease the effectiveness of the neuroleptic heloperidol varied widely. Most severely attenuated was production of catalepsy followed in order of decreasing interference by inhibition of amphetamine-induced rotation, inhibition of amphetamine- or apomorphine-induced stereotyped behavior, inhibition of conditioned avoidance responding and lastly attenuation of the haloperidol-induced increase in striatal HVA. By use of such a relatively low dose of scopolamine the behavioral effects of heloperidol were dissociated from effects on dopamine turnover in the striatum. If behavioral tests in animals can be related to the clinical effects of neuroleptic drugs, those effects of haloperidol severely reduced by scopolamine may be related to extrapyramidal effects.


Jun 1, 1975·The Journal of Pharmacy and Pharmacology·G BartholiniA Pletscher
Nov 7, 1975·Science·P M GrovesG V Rebec
Feb 1, 1972·British Journal of Pharmacology·M B Bowers, R H Roth
Dec 1, 1974·The Journal of Pharmacy and Pharmacology·P Muller, P Seeman
Jun 1, 1971·The Journal of Pharmacy and Pharmacology·N E Andén, P Bédard


Jan 1, 1980·Psychopharmacology·T C De Lima, J Palermo Neto
Nov 19, 1981·European Journal of Pharmacology·R D SturgeonH Y Meltzer
Jun 10, 1981·European Journal of Pharmacology·J T McDevitt, P E Setler
May 28, 1985·European Journal of Pharmacology·C ScavoneM L Aizenstein
May 10, 1988·European Journal of Pharmacology·Roberto Frussa-Filho, J Palermo-Neto
Aug 11, 1989·European Journal of Pharmacology·M R Sandoval, J Palermo-Neto
Jul 1, 1982·Neuropharmacology·A CampbellR J Baldessarini
Jan 1, 1987·Physiology & Behavior·L F FelicioJ Palermo-Neto
Oct 1, 1991·Physiology & Behavior·Roberto Frussa-Filho, J Palermo-Neto
Dec 1, 1991·Pharmacology, Biochemistry, and Behavior·D Wirtshafter, K E Asin
Sep 1, 1991·Pharmacology, Biochemistry, and Behavior·S Chiavegatto, M M Bernardi
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·M L AizensteinR DeLucia
Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·A RobertsonC MacDonald
Jan 1, 1984·General Pharmacology·R DeLuciaM L Aizenstein
Jan 1, 1987·General Pharmacology·A Poli, J Palermo-Neto
Jan 1, 1990·General Pharmacology·J Palermo-Neto, V A Dorce
Jan 1, 1990·General Pharmacology·Jorge Camilo Flório, J Palermo-Neto
Oct 1, 1994·General Pharmacology·A R RigonR N Takahashi
Jan 1, 1980·Neuroscience·C J Pycock
Aug 1, 1992·Brain Research Bulletin·V A Dorce, J Palermo-Neto
Mar 1, 1990·Journal of Ethnopharmacology·S L GórniakH de Souza-Spinosa
Jan 1, 1995·Journal of Ethnopharmacology·M J BatatinhaM M Bernardi
Apr 23, 2003·Life Sciences·V C AbílioRoberto Frussa-Filho
Apr 28, 2001·Pharmacology, Biochemistry, and Behavior·E E HuckeL F Felicio
Jul 27, 1999·Pharmacology, Biochemistry, and Behavior·A C FerrazC Da Cunha
Apr 3, 1999·General Pharmacology·J Palermo-NetoM A B F Vital
Sep 24, 1999·Neurotoxicology and Teratology·A C MonizM M Bernardi
Jun 29, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S R JocaR Andreatini
Mar 12, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J C PerryJ Palermo-Neto
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cibele Cristina ChinenRoberto Frussa-Filho
Aug 1, 1993·Pharmacology & Toxicology·Jorge Camilo FlórioJ Palermo-Neto
Jul 21, 1998·Annals of the New York Academy of Sciences·M B VitalJ Palermo-Neto
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·Roberto Frussa-FilhoJ Palermo-Neto
Jun 22, 1999·Biological Psychiatry·V C AbílioRoberto Frussa-Filho
Sep 30, 2015·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Thaísa M SandiniH S Spinosa
Jul 29, 2010·The Journal of Pharmacy and Pharmacology·Eduardo L G MoreiraRosa Maria Ribeiro-do-Valle
Jun 9, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Aline R BorçoiRoberto Frussa-Filho
Sep 3, 2013·Toxicon : Official Journal of the International Society on Toxinology·Luciana A CholichOfelia C Acosta
Jun 19, 2004·Neurotoxicology and Teratology·C A LazariniM M Bernardi
Jul 1, 2008·Neurotoxicology and Teratology·Plinio das N FavaroEstefânia Gastaldello Moreira
Jul 12, 2005·Neurotoxicology and Teratology·A C MonizM M Bernardi
Sep 6, 2005·Human & Experimental Toxicology·C Q MoreiraEstefânia Gastaldello Moreira
Feb 1, 1982·The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology·E Murzi, L J Herberg
Jun 20, 2019·Current Protocols in Neuroscience·Fausto Pierdoná GuzenDayane Pessoa de Araújo
Apr 10, 2021·Behavioural Brain Research·Camila RigobelloEstefânia Gastaldello Moreira

Related Concepts

Avoidance Learning
Waxy Flexibility
Lentiform Nucleus Structure
Dose-Response Relationship, Drug
Homovanillic Acid
Rats, Inbred F344
Isopto Hyoscine

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.